19 Luglio 2026

chemotherapy

Pfizer’ s BRAFTOVI* Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer #ASCO26 intestino microbiota batteri

Pfizer’ s BRAFTOVI* Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer #ASCO26

Redazione 2 Giugno 2026
Pfizer announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase...
Per saperne di più Maggiori informazioni su Pfizer’ s BRAFTOVI* Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer #ASCO26
FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer Schermata 2025-10-03 alle 18.43.19

FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer

Redazione 3 Ottobre 2025
PharmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin)...
Per saperne di più Maggiori informazioni su FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients

Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients

Redazione 13 Agosto 2025
For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes...
Per saperne di più Maggiori informazioni su Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients
Esophageal cancer, is chemotherapy before and after surgery a new standard treatment? #ASCO24

Esophageal cancer, is chemotherapy before and after surgery a new standard treatment? #ASCO24

Redazione 3 Giugno 2024
For patients with locally advanced esophageal adenocarcinoma that can be treated with surgery, chemotherapy treatment before and...
Per saperne di più Maggiori informazioni su Esophageal cancer, is chemotherapy before and after surgery a new standard treatment? #ASCO24
FDA approves fam-trastuzumab-deruxtecan-nxki (Enhertu*), first targeted Therapy for HER2-Low breast cancer

FDA approves fam-trastuzumab-deruxtecan-nxki (Enhertu*), first targeted Therapy for HER2-Low breast cancer

Redazione 5 Agosto 2022
Today, the U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of...
Per saperne di più Maggiori informazioni su FDA approves fam-trastuzumab-deruxtecan-nxki (Enhertu*), first targeted Therapy for HER2-Low breast cancer
Chemo Within 3 Months of coronavirus COVID-19 Diagnosis Associated With an Increased Risk of Death in Patients With Thoracic Cancer #ASCO20

Chemo Within 3 Months of coronavirus COVID-19 Diagnosis Associated With an Increased Risk of Death in Patients With Thoracic Cancer #ASCO20

Redazione 31 Maggio 2020
Among patients with lung and other thoracic cancers also diagnosed with COVID-19, prior use of chemotherapy —...
Per saperne di più Maggiori informazioni su Chemo Within 3 Months of coronavirus COVID-19 Diagnosis Associated With an Increased Risk of Death in Patients With Thoracic Cancer #ASCO20